Complications of Total Hip Arthroplasty in Patients With Ankylosing Spondylitis
Overview
Authors
Affiliations
Objective: To compare the risks of complications of primary total hip arthroplasty (THA) between patients with ankylosing spondylitis (AS) and those without AS.
Methods: In this population-based study, we examined data from 1999 to 2013 of US Medicare beneficiaries (ages <75 years old) with AS and a comparison group without AS who had undergone primary THA. Complications were based on the Centers for Medicare & Medicaid Services 2013 THA Complication Measure, which included myocardial infarction, pneumonia, or sepsis within 7 days; surgical site bleeding, pulmonary embolus, or venous thrombosis within 30 days; or mechanical complications or local infection within 90 days. Mortality within 90 days, revision arthroplasty within 1 year, long length of stay, discharge to a care facility, and readmission within 90 days were also examined.
Results: The study included 2,773 patients with AS and 107,341 patients without AS who had THA. Perioperative complications, 30-day complications, and local infections were rare in both groups (<1%). Mechanical complications and revision arthroplasty were uncommon in both groups. Ninety-day mortality was lower among patients with AS than those without AS (0.36% versus 0.7%). Patients with AS were more likely to be discharged to a care facility, and slightly more likely to have a long length of stay. Likelihood of a long stay was lower at hospitals that performed ≥100 THAs per year, but other complications were not associated with hospital volume.
Conclusion: Complications after primary THA are uncommon in patients with AS and similar in frequency to those without AS. Ninety-day mortality was lower among patients with AS.
Ruangsomboon P, Bagouri E, Pincus D, Paterson J, Ravi B Acta Orthop. 2024; 95:505-511.
PMID: 39254644 PMC: 11387785. DOI: 10.2340/17453674.2024.41506.
Navigating the Factors Affecting Functional Impairment in Spondyloarthritis.
Maatallah K, Cherif I, Ferjani H, Nessib D, Boumaiza R, Kaffel D Sultan Qaboos Univ Med J. 2024; 24(2):235-242.
PMID: 38828242 PMC: 11139368. DOI: 10.18295/squmj.3.2024.023.
An Overview of Adalimumab Therapy for Ankylosing Spondylitis.
Sukhanova A, Gilavian M, Melnik E, Shikh E, Petukhov A, Gegechkori V Curr Rheumatol Rev. 2024; 20(5):501-513.
PMID: 38415452 PMC: 11340288. DOI: 10.2174/0115733971289295240223095751.
Goel A, Viswanathan V, Serbin P, Youngman T, Mounasamy V, Sambandam S J Clin Orthop Trauma. 2023; 39:102151.
PMID: 37123430 PMC: 10130334. DOI: 10.1016/j.jcot.2023.102151.
Tsai S, Lau N, Chen W, Chien R, Tischler E, Fu T J Orthop Surg Res. 2022; 17(1):353.
PMID: 35842632 PMC: 9288065. DOI: 10.1186/s13018-022-03237-8.